These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8081009)

  • 21. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.
    Juliusson G; Heldal D; Hippe E; Hedenus M; Malm C; Wallman K; Stolt CM; Evensen SA; Albertioni F; Tjønnfjord G
    J Clin Oncol; 1995 Apr; 13(4):989-95. PubMed ID: 7707128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 23. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia.
    Tallman MS; Hakimian D; Variakojis D; Koslow D; Sisney GA; Rademaker AW; Rose E; Kaul K
    Blood; 1992 Nov; 80(9):2203-9. PubMed ID: 1358262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary splenic hairy cell leukemia--remission for 21 years following splenectomy.
    Myers TJ; Ikeda Y; Schwartz S; Pharmakidis AB; Baldini MG
    Am J Hematol; 1981 Nov; 11(3):299-303. PubMed ID: 7315843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remission in hairy cell leukemia-variant following splenic radiotherapy alone.
    Sgarabotto D; Vianello F; Radossi P; Poletti A; Sotti G; Stefani PM; Sartori R; Girolami A
    Leuk Lymphoma; 1997 Jul; 26(3-4):395-8. PubMed ID: 9322903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral facial nerve palsy as first indication of relapsing hairy cell leukemia after 36 years.
    Ferrari J; Lang W; Thurnher S; Müllauer L; Raderer M
    Neurology; 2004 Jul; 63(2):399-400. PubMed ID: 15277655
    [No Abstract]   [Full Text] [Related]  

  • 27. Hairy cell leukaemia-variant: Disease features and treatment.
    Matutes E; Martínez-Trillos A; Campo E
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):253-63. PubMed ID: 26614904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral blood and bone marrow changes following 2'-deoxycoformycin therapy in hairy cell leukemia. Results of 200 weeks' follow-up.
    Dalal BI; Freier L; Johnston JB; Merry CC; Israels LG
    Cancer; 1989 Jan; 63(1):14-22. PubMed ID: 2783375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Lauria F; Benfenati D; Raspadori D; Rondelli D; Zinzani PL; Tura S
    Leuk Lymphoma; 1993 Nov; 11(5-6):399-404. PubMed ID: 7907247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hairy-cell leukemia.
    Lill MC; Golde DW
    Blood Rev; 1990 Dec; 4(4):238-44. PubMed ID: 1706207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
    Zák P; Chrobák L; Dĕdic K; Podzimek K
    Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine--a report of three cases.
    Blasińska-Morawiec M; Robak T; Krykowski E; Hellmann A; Urbańska-Ryś H
    Leuk Lymphoma; 1997 Apr; 25(3-4):381-5. PubMed ID: 9168448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of 2-chlorodeoxyadenosine in nodal and extra haematopoietic localizations in hairy cell leukaemia.
    Rieux C; Bastion Y; Bazin M; Dumontet C; Coiffier B; Felman P; Bryon PA
    Eur J Haematol; 1995 Aug; 55(2):133-5. PubMed ID: 7628589
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Jehn U; Bartl R; Dietzfelbinger H; Vehling-Kaiser U; Wolf-Hornung B; Hill W; Heinemann V
    Ann Hematol; 1999 Mar; 78(3):139-44. PubMed ID: 10211756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues.
    Larsen CR; Hansen PB; Clausen NT
    Am J Hematol; 2002 May; 70(1):48-50. PubMed ID: 11994981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-CdA in the treatment of hairy cell leukaemia.
    Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH
    J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hairy cell leukemia-variant--a case report.
    Gupta K; Jasmina A; Malhotra P; Varma N; Vaiphei K; Vohra H; Varma S; Garewal G
    Indian J Pathol Microbiol; 2005 Jul; 48(3):387-9. PubMed ID: 16761764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
    Cheson BD
    Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of alpha-interferon therapy on bone marrow fibrosis in hairy cell leukemia.
    Laughlin M; Islam A; Barcos M; Meade P; Ozer H; Gavigan M; Henderson E; Han T
    Blood; 1988 Sep; 72(3):936-9. PubMed ID: 3416078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.